Physician profile
Mark C Pillitteri
NPI 1679677082
$2,324.98
in general payments reported to CMS, 2019-2025
20 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $973 · 2020: $61.53 · 2021: $154 · 2022: $838 · 2023: $65.07 · 2024: $26.70 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $272 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.83 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,178.48 | 2019-2022 | |
| Abbvie INC. | $175.94 | 2019-2023 | |
| Olympus America INC. | $163.06 | 2019-2020 | |
| Medtronic, INC. | $160.64 | 2025 | Ligasure |
| Avion Pharmaceuticals | $82.80 | 2019-2022 | |
| Applied Medical Resources Corporation | $69.93 | 2021 | |
| Exeltis, USA INC. | $63.02 | 2019-2020 | |
| Allergan, INC. | $53.29 | 2019 | |
| Pfizer INC. | $52.40 | 2019-2022 | |
| Ethicon US, LLC | $46.12 | 2025 | Surgiflo Hemostatic Matrix, Surgicel Nu-Knit, Vistaseal |
| Lupin INC. | $44.51 | 2019 | |
| Coopersurgical, INC. | $40.45 | 2022 | |
| Roche Diagnostics Corporation | $38.00 | 2019 | |
| Davol INC. | $29.41 | 2022 | |
| Stryker Corporation | $26.98 | 2023 | Stryker |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $26.70 | 2024 | |
| Myovant Sciences INC. | $26.40 | 2022 | |
| Virtus Pharmaceuticals LLC | $18.12 | 2020-2021 | |
| Hologic Sales and Service, LLC | $17.09 | 2021 | |
| Mission Pharmacal Company | $11.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Pillitteri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.